147 related articles for article (PubMed ID: 17118310)
1. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.
Martínez-Monge R; Jurado M; Cambeiro M; Valero J; Villafranca E; Alcázar JL
Brachytherapy; 2006; 5(4):203-10. PubMed ID: 17118310
[TBL] [Abstract][Full Text] [Related]
2. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.
Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C
Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995
[TBL] [Abstract][Full Text] [Related]
3. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer.
Martínez-Monge R; Gómez-Iturriaga A; Cambeiro M; Garrán C; Montesdeoca N; Aristu JJ; Alcalde J
Brachytherapy; 2009; 8(1):26-33. PubMed ID: 19041280
[TBL] [Abstract][Full Text] [Related]
4. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas.
Martínez-Monge R; Garrán C; Cambeiro M; San Julián M; Alcalde J; Sierrasesúmaga L
Brachytherapy; 2004; 3(4):196-200. PubMed ID: 15607151
[TBL] [Abstract][Full Text] [Related]
5. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
[TBL] [Abstract][Full Text] [Related]
6. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial.
Martínez-Monge R; Valtueña Peydró G; Cambeiro M; Aramendía JM; Gimeno M; Santisteban M; Lecanda F; Minguez JA; Alcázar JL; Jurado M
Brachytherapy; 2018; 17(5):734-741. PubMed ID: 29803537
[TBL] [Abstract][Full Text] [Related]
7. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience.
Brabham JG; Cardenes HR
Am J Clin Oncol; 2009 Aug; 32(4):417-22. PubMed ID: 19451799
[TBL] [Abstract][Full Text] [Related]
8. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
10. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
11. Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies.
Tran PT; Su Z; Hara W; Husain A; Teng N; Kapp DS
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):504-11. PubMed ID: 17560736
[TBL] [Abstract][Full Text] [Related]
12. Perioperative high-dose-rate brachytherapy in soft tissue sarcomas of the extremity and superficial trunk in adults: initial results of a pilot study.
Martínez-Monge R; San Julián M; Amillo S; Cambeiro M; Arbea L; Valero J; González-Cao M; Martín-Algarra S
Brachytherapy; 2005; 4(4):264-70. PubMed ID: 16344256
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM
Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298
[TBL] [Abstract][Full Text] [Related]
14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent pelvic and selected primary gynecologic malignancies with 241Am.
Chung JY; Roberts K; Peschel RE; Nath R; Pourang R; Kacinski B; Wilson L
Radiat Oncol Investig; 1997; 5(5):227-34. PubMed ID: 9372545
[TBL] [Abstract][Full Text] [Related]
16. Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies.
Kasibhatla M; Clough RW; Montana GS; Oleson JR; Light K; Steffey BA; Jones EL
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):398-403. PubMed ID: 16542793
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
[TBL] [Abstract][Full Text] [Related]
18. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
19. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.
Larsen SG; Wiig JN; Tretli S; Giercksky KE
Colorectal Dis; 2006 Mar; 8(3):177-85. PubMed ID: 16466556
[TBL] [Abstract][Full Text] [Related]
20. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
Martínez-Monge R; Pagola Divassón M; Cambeiro M; Gaztañaga M; Moreno M; Arbea L; Montesdeoca N; Alcalde J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e245-54. PubMed ID: 21620582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
